As the angiotensin-converting enzyme (ACE) receptors are widely spread throughout the nervous system, it is pathologically plausible to connect COVID-19 infection and neurological complications including GBS/MFS through direct neurological invasion and/or immune-mediated neurological damage [17]. The gene discussed is ACE; the disease is Guillain-Barre syndrome.